Tangible Asset Valuation

Our team can help you with valuation of plant & machinery across various asset classes and industries. Based on your client’s specific business requirements, our team helps you prepare customized analyses and reports.
The reason for getting a personal property valued could vary from financial reporting requirement or external funding requirement to buying and selling machinery and risk regulation. Knowcraft Analytics helps your firm at various steps by assisting in research, carrying out a detailed valuation of tangible assets, and developing a report to support your analysis.

External and Audit Projects for Purchase Price Allocations and Impairment Testing

Desktop Valuation of Plant, Machinery and Equipment

Report Writing

Secondary Market Research Assistance – Market Value

Why Choose Knowcraft for Valuation?

Executed Over 10,000 Engagements
Acted as an Advisor to Help Clients Venture into New Service Offerings
Reduced Turn around Time by ~40%
Helped Scale Businesses from a Single-Member Team to a 40+ Member Strong Team
Enabled Business Growth through 50%-100% Increase in Revenue and 30%-50% Improved Margins

Case Studies

Contingent Consideration Valuation

Contingent Consideration Valuation

THE CLIENT AND THE ASK: A pharmaceutical company (the “Acquirer”) acquired a biotechnology company (the “Company”) in exchange for an upfront payment and certain payments contingent upon successful achievement of future regulatory and sales milestones for certain...

Forecasting and Valuation

Forecasting and Valuation

THE COMPANY AND THE ASK: The Company is a technology company with a business proposition to provide diagnostic services to rural India and reduce the turnaround time of getting the report from 24 hours to 1 hour. The Company was operating using multiple business...

IRC – 409A Valuation of Common Stock

IRC – 409A Valuation of Common Stock

THE COMPANY: A biotechnology company (the “Company”) engaged in the development of an Influenza vaccine as its flagship product with others in the pipeline. The lead drug was in the pre-clinical phase of development, as of the date of valuation. The Company had raised...

Contact Us
Linkedin
Instagram